PT709378E - Aminoalquiloximas processo para a sua preparacao sua utilizacao como medicamentos e compostos intermediarios - Google Patents
Aminoalquiloximas processo para a sua preparacao sua utilizacao como medicamentos e compostos intermediariosInfo
- Publication number
- PT709378E PT709378E PT95111895T PT95111895T PT709378E PT 709378 E PT709378 E PT 709378E PT 95111895 T PT95111895 T PT 95111895T PT 95111895 T PT95111895 T PT 95111895T PT 709378 E PT709378 E PT 709378E
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- aminoalquiloximas
- medicines
- intermediate compounds
- aminoalkyloxines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/285,668 US5665756A (en) | 1994-08-03 | 1994-08-03 | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT709378E true PT709378E (pt) | 2003-06-30 |
Family
ID=23095223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95111895T PT709378E (pt) | 1994-08-03 | 1995-07-28 | Aminoalquiloximas processo para a sua preparacao sua utilizacao como medicamentos e compostos intermediarios |
Country Status (9)
| Country | Link |
|---|---|
| US (8) | US5665756A (pt) |
| EP (1) | EP0709378B1 (pt) |
| JP (1) | JP3947238B2 (pt) |
| AT (1) | ATE234820T1 (pt) |
| CA (1) | CA2155275C (pt) |
| DE (1) | DE69529958T2 (pt) |
| DK (1) | DK0709378T3 (pt) |
| ES (1) | ES2194033T3 (pt) |
| PT (1) | PT709378E (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60045751D1 (de) * | 1999-09-30 | 2011-04-28 | Harbor Biosciences Inc | Therapeutische Behandlung androgenrezeptorbedingter Leiden |
| DE19952146A1 (de) * | 1999-10-29 | 2001-06-07 | Boehringer Ingelheim Pharma | Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US7256191B2 (en) * | 2000-04-24 | 2007-08-14 | Aryx Therapeutics | Materials and methods for the treatment of depression |
| WO2001080845A2 (en) | 2000-04-24 | 2001-11-01 | Aryx Therapeutics | (2-aminoethyl) oxime derivatives for the treatment of depression |
| US8193768B2 (en) * | 2008-02-28 | 2012-06-05 | Jason S. Hallett | Contactless charging system for musical instruments |
| US11498903B2 (en) | 2017-08-17 | 2022-11-15 | Bristol-Myers Squibb Company | 2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3692835A (en) * | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
| BE759128R (fr) * | 1969-11-18 | 1971-05-18 | Usv Pharma Corp | Carbamoyl oximes et leur methode de |
| FR2162312B1 (pt) * | 1971-12-10 | 1975-02-07 | Buzas Andre | |
| FR2215953B2 (pt) * | 1973-02-05 | 1976-05-14 | Buzas Andre | |
| NL7503313A (en) * | 1975-03-20 | 1976-09-22 | Philips Nv | Antiaggressive oxime ethers - viz 4-nitro-2-butyl(oxy)-acetophenone O-aminoalkyl-oximes |
| NL7503310A (nl) * | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| US4192893A (en) * | 1975-03-20 | 1980-03-11 | U.S. Philips Corporation | Anti-depressive compounds |
| NL7610399A (en) * | 1976-09-20 | 1978-03-22 | Philips Nv | O-Aminoethyl oxime derivs. of halophenyl ketone cpds. - are selective nor-adrenalin potentiators useful as antidepressants |
| AT364354B (de) * | 1976-10-14 | 1981-10-12 | Byk Gulden Lomberg Chem Fab | Verfahren zur herstellung von neuen pyrazol-1yl-phenylessigsaeuren, deren salzen und optischen isomeren |
| DE2658938A1 (de) * | 1976-12-24 | 1978-07-06 | Hoechst Ag | Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE2658762A1 (de) * | 1976-12-24 | 1978-06-29 | Hoechst Ag | Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4297359A (en) * | 1978-07-25 | 1981-10-27 | Acf Chemiefarma Nv | Anti-ulcer compositions containing certain pyridyl oxime ethers |
| US4352804A (en) * | 1978-07-25 | 1982-10-05 | Acf Chemiefarma Nv | Oxime ethers, their preparation and pharmaceutical compositions containing them |
| AU532700B2 (en) * | 1979-04-02 | 1983-10-13 | Sumitomo Chemical Company, Limited | Diphenylalkanoether |
| DE3019497A1 (de) * | 1980-05-22 | 1981-11-26 | Bayer Ag, 5090 Leverkusen | Aminopropiophenon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| DE3070002D1 (en) * | 1980-06-07 | 1985-03-07 | Hell Rudolf Dr Ing Gmbh | Process for operating a high stability electron gun for the shaping of materials |
| EP0053017B1 (en) * | 1980-11-24 | 1985-02-20 | Imperial Chemical Industries Plc | Amide derivatives |
| US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
| JPS6463574A (en) * | 1987-09-03 | 1989-03-09 | Mitsubishi Chem Ind | Ethanone oximes |
| GB8811056D0 (en) * | 1988-05-10 | 1988-06-15 | Ici Plc | Antibiotic compounds |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| DE3927483A1 (de) * | 1989-08-19 | 1991-02-21 | Boehringer Ingelheim Kg | Neue substituierte heterocyclische fuenfringe, ihre herstellung und verwendung |
| IL97144A (en) * | 1990-02-27 | 1994-11-28 | Erba Carlo Spa | History of 1-) Alkoxy-Iminoalkyl (Imidazole Transformed Preparation and Pharmaceutical Preparations Containing Them |
-
1994
- 1994-08-03 US US08/285,668 patent/US5665756A/en not_active Expired - Lifetime
-
1995
- 1995-06-01 US US08/457,259 patent/US5684021A/en not_active Expired - Lifetime
- 1995-06-01 US US08/457,081 patent/US5648367A/en not_active Expired - Lifetime
- 1995-06-01 US US08/457,681 patent/US5686446A/en not_active Expired - Lifetime
- 1995-06-01 US US08/456,969 patent/US5696142A/en not_active Expired - Lifetime
- 1995-06-01 US US08/458,147 patent/US5686447A/en not_active Expired - Lifetime
- 1995-06-01 US US08/457,422 patent/US5686483A/en not_active Expired - Lifetime
- 1995-07-28 DK DK95111895T patent/DK0709378T3/da active
- 1995-07-28 DE DE69529958T patent/DE69529958T2/de not_active Expired - Fee Related
- 1995-07-28 ES ES95111895T patent/ES2194033T3/es not_active Expired - Lifetime
- 1995-07-28 AT AT95111895T patent/ATE234820T1/de not_active IP Right Cessation
- 1995-07-28 PT PT95111895T patent/PT709378E/pt unknown
- 1995-07-28 EP EP95111895A patent/EP0709378B1/en not_active Expired - Lifetime
- 1995-08-02 JP JP19720995A patent/JP3947238B2/ja not_active Expired - Fee Related
- 1995-08-02 CA CA002155275A patent/CA2155275C/en not_active Expired - Fee Related
-
1997
- 1997-07-29 US US08/902,462 patent/US5770740A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5684021A (en) | 1997-11-04 |
| US5686483A (en) | 1997-11-11 |
| US5696142A (en) | 1997-12-09 |
| US5648367A (en) | 1997-07-15 |
| US5686446A (en) | 1997-11-11 |
| DE69529958T2 (de) | 2004-01-08 |
| CA2155275C (en) | 2007-05-15 |
| DK0709378T3 (da) | 2003-07-14 |
| EP0709378B1 (en) | 2003-03-19 |
| US5665756A (en) | 1997-09-09 |
| JP3947238B2 (ja) | 2007-07-18 |
| US5770740A (en) | 1998-06-23 |
| EP0709378A2 (en) | 1996-05-01 |
| CA2155275A1 (en) | 1996-02-04 |
| ES2194033T3 (es) | 2003-11-16 |
| ATE234820T1 (de) | 2003-04-15 |
| US5686447A (en) | 1997-11-11 |
| DE69529958D1 (de) | 2003-04-24 |
| JPH0859617A (ja) | 1996-03-05 |
| EP0709378A3 (en) | 1996-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9812837A (pt) | Processo para fazer um composto, e, composto | |
| NO932870D0 (no) | Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner | |
| BR9909844A (pt) | Processo para sintetizar um composto, e, composto. | |
| MX9205532A (es) | Nuevas 7-sustituidas-9-amino sustituidas 6-desmetil-6-desoxitetraciclinas, metodo para su producciony composicion farmaceutica que las contiene. | |
| BR1100131A (pt) | ácidos hidroxâmicos substituìdos por arilsulfonamido | |
| IL107843A0 (en) | Aminomethylene substituted non-aromatic heterocycles | |
| ATE145914T1 (de) | Anticonvulsive fructopyranose zyklische sulfate und sulfite | |
| EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
| FI113651B (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsoliyhdisteiden valmistamiseksi | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| DK1109817T3 (da) | Phosphohalogenhydriner, deres fremstilling og anvendelse | |
| PT902022E (pt) | Novos derivados de benzofuranona e processo para a sua producao | |
| MX9304353A (es) | Aminotienopiridinas sustituidas, procedimiento para su preparacion y su uso como medicamento. | |
| PT709378E (pt) | Aminoalquiloximas processo para a sua preparacao sua utilizacao como medicamentos e compostos intermediarios | |
| BR9808923A (pt) | Composto, e, processo para fazer o mesmo | |
| BR9401156A (pt) | Processo para a produção de um composto de alcoxiiminoacetamida | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE223414T1 (de) | Prozess zur herstellung von zwischebprodukten für imidazodeazepinen | |
| BR9707004A (pt) | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento | |
| DE69533214D1 (de) | 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme | |
| DE69808922D1 (de) | Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen | |
| BR9902051A (pt) | Oxidação seletiva e a preparação de compostos aromáticos contendo grupos hidroxila. | |
| PT1250335E (pt) | Processo e intermediarios para a preparacao de imidazopiridinas | |
| BR0211480A (pt) | Derivados de tetraidropiridazina e seu uso como pesticidas |